Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Studies in the United States and the United Kingdom have reported an increased risk of cholecystectomy among women exposed to menopausal hormone therapy, but with substantial heterogeneity between types of hormone treatments. We evaluated the risk of cholecystectomy associated with different regimens of menopausal hormone therapy in a large prospective cohort study. METHODS: Between 1992 and 2008, 70 928 menopausal women from the French E3N study cohort were sent questionnaires assessing their use of menopausal hormone therapy, medical history and lifestyle characteristics. The primary outcome was cholecystectomy. We analyzed the risk of cholecystectomy associated with use of menopausal hormone therapy using Cox proportional models, with age as time-scale. RESULTS: During follow-up, 45 984 (64.8%) of the participants were exposed to menopausal hormone therapy, and 2819 cholecystectomies were recorded. The use of menopausal hormone therapy was associated with an increased risk of cholecystectomy (adjusted hazard ratio [HR] 1.10, 95% confidence interval [CI] 1.01-1.20) compared with women who were not exposed to menopausal hormone therapy. The association was restricted to unopposed oral estrogen therapy (adjusted HR 1.38, 95% CI 1.14-1.67). Over 5 years, about 1 cholecystectomy in excess would be expected in every 150 women using oral estrogen therapy without progestogens, compared with women not exposed to menopausal hormone therapy. INTERPRETATION: The risk of cholecystectomy was increased among women exposed to oral estrogen menopausal hormone therapy, especially oral regimens without a progestagen. Complicated gallstone disease should be added to the list of potential adverse events to be considered when balancing the benefits and risks associated with menopausal hormone therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Lauzon-Guillain, B., Fournier, A., Fabre, A., Simon, N., Mesrine, S., Boutron-Ruault, M.-C., Balkau, B., & Clavel-Chapelon, F. (2009) · Diabetologia · doi:10.1007/s00125-009-1456-y · Cited by 86
Self-citation
Cited by
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
“Observational studies report increased risk with oral, but not transdermal, estradiol (121, 122) and increased dose and duration (120, 123).”
BackgroundDiet and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort
Barré, A., Gusto, G., Cadeau, C., Carbonnel, F., & Boutron-Ruault, M.-C. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.216 · Cited by 23
Self-citationNordenvall, C., Oskarsson, V., & Wolk, A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1298-6 · Cited by 16
Metadata
- Authors
- Racine, A., Bijon, A., Fournier, A., Mesrine, S., Clavel-Chapelon, F., Carbonnel, F., & Boutron-Ruault, M.-C.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2013-03-18
- Volume
- 185
- Issue
- 7
- Pages
- 555-561
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W1967374444
- Cited by
- 43
- References
- 1
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort. https://app.cochat.ai/papers/10.1503/cmaj.121490
- The paper
- Racine, A., Bijon, A., Fournier, A., Mesrine, S., Clavel-Chapelon, F., Carbonnel, F., & Boutron-Ruault, M.-C. (2013). Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.121490
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.